Sign in

CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

SAB Biotherapeutics, Inc.

Sign in to watch
Ticker
SABS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
853899721
Phone
305-845-2813
Business address
777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
Former names
Big Cypress Acquisition Corp.
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 8-K Event Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events
  4. UPLOAD Other SEC-generated Letter
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. UPLOAD Other SEC-generated Letter
  7. EFFECT Other Notice of Effectiveness
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. UPLOAD Other SEC-generated Letter
  10. S-3 Offering Registration Statement
  11. 8-K Event Auditor change
  12. 10-Q Report Quarterly Report
  13. NT 10-Q Other NT 10-Q
  14. 8-K Event Auditor change
  15. AW Other AW
  16. POS AM Other Post-effective Amendment for Registration Statement
  17. 8-K Event Shareholder vote results
  18. RW Other RW
  19. 8-K Event Regulation FD disclosure
  20. 8-K Event Regulation FD disclosure

Page 10 of 22 · 433 filings